Home > Boards > US OTC > Delisted > Cannabis Science Inc. (fka CBIS)

Largest cannabis deal in history goes down

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
DouglasJH Member Profile
 
Followed By 0
Posts 872
Boards Moderated 0
Alias Born 08/28/09
160x600 placeholder
Kansas City Fed Services Activity Index Rises in January
By Colin Kellaher
Apple Up Over 5%, on Track for Largest Percent Increase Since October 2020 -- Data Talk
Intel on Track for Lowest Close Since December 2020 -- Data Talk
Visa Up Over 5%, on Pace for Largest Percent Increase Since November 2020 -- Data Talk
Oil Prices Seen at $78 This Year as Supply Hikes Lag Demand
US Consumer Sentiment Wanes in Late January to Decade-Low on Inflation Concerns
Insulet Shares Rally on FDA Approval of Omnipod 5
Provention Bio Shares Rise 13% After Plan to Resubmit BLA
Pfizer Gets EC OK for Lorviqua as First-Line Treatment for ALK-Positive Advanced Lung Cancer
Citi Works With Five Black-Owned Firms on Bond Issuance
Top Company News of the Day
U.S. Consumer Spending Fell 0.6% in December
Eli Lilly Reports Olumiant Setbacks in Lupus, Atopic Dermatitis
FTSE Down, Long Gilts Could Remain in Sweet Spot
Colgate-Palmolive Expects Earnings Growth This Year
Chevron Hits Production High in 2021, Net Output Down 5% in 4Q -- Energy Comment
Regeneron, Sanofi Pull FDA Application for Libtayo in Advanced Cervical Cancer
Bristol Myers Gets Positive CHMP Opinion For Breyanzi in Lymphoma
Colgate-Palmolive 4Q Profit Falls, Hit by Higher Costs
Merck: Molnupiravir Covid-19 Pill Effective Against Omicron in Lab Tests
EUROPEAN MIDDAY BRIEFING - Stocks Fall Ahead of Expected Mixed US Open
Insulet Gets FDA OK for Omnipod 5 Automated Insulin-Delivery System
North American Morning Briefing: S&P 500, Dow on Track for Fourth Weekly Loss
BOE Seen Trying to Encourage Stronger Pound, Says ING
Givaudan Shares Slide on Weak Profitability, Costs Impact
Belgian Economy Grew in 4Q at a Slower Pace
FTSE 100 Drops as Oil, Mining, Financial Stocks Fall
Henkel Shares Slide as 2022 Targets Fall Short of Consensus
DouglasJH   Wednesday, 05/04/11 02:52:59 AM
Re: DouglasJH post# 24036
Post # of 129039 
Largest cannabis deal in history goes down

http://pr.cannazine.co.uk/201104201431/green/eco-news/largest-cannabis-deal-in-history-goes-down.html
Quote:
The company which has covered the fields of southern England with over 90,000 medical cannabis plants in three huge greenhouses has closed a deal which will be recorded as the largest illicit cannabis sale in history when you bear in mind the legal status of cannabis.

For over ten years, fledgling UK biotech firm GW Pharmaceuticals has been developing its cannabis based medicine 'Sativex', and the decade of investment is finally paying off, with some of the biggest pharmaceuticals in existence finally sitting up and taking note of the benefits of cannabis.

Swiss based Novartis is the latest in a long line of pharmaceutical drug manufacturers to sign up with GW Pharmaceuticals, following other notable cannabis vendors such as Otsuka in the US and Bayer, who holds the UK distribution licence for Sativex.

Who Says Money Doesn't Grow on Tree's?

The Novartis deal sees GW receive a $5 million down payment followed by a further $28 million is so called 'mile-stone payments, which come into force when sales achieve certain levels.
In the meantime the UK government still refuses to acknowledge the medical benefits that come with cannabis. And whilst its widely accepted its not all 'good news' with cannabis, European governments and the US administration are already looking at how the medical marijuana market can be better controlled.

Allowing access to those who need the cannabis the most, whilst at the same time offering education and awareness to recreational users.



Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist
Consent Preferences